β-Ketoenamine covalent organic framework nanoplatform combined with immune checkpoint blockade via photodynamic immunotherapy inhibit glioblastoma progression.
Yan T, Liao Q, Chen Z, Xu Y, Zhu W, Hu P, Zhang S, Wu Y, Shu L, Liu J, Luo M, Shu H, Sheng Y, Wang L, Xu C, Lei C, Wang H, Ye Q, Yang L, Zhu X.
Yan T, et al. Among authors: luo m.
Bioact Mater. 2024 Nov 7;44:531-543. doi: 10.1016/j.bioactmat.2024.10.029. eCollection 2025 Feb.
Bioact Mater. 2024.
PMID: 39584065
Free PMC article.